Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Valesca Retèl

22PUBLICATIONS

52CO-AUTHORS

Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples youth and familyCancer diagnosis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|Dec 31, 2025

Hospital-based real-world evidence in health technology assessment: insights from a scoping review of European, Australian and North American guidance and expert interviews.

Zainab Al-Khayat, Nora Franzen, Valesca P Retèl

|Dec 19, 2025

Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer.

Madelief Schreuder Goedheijt, Ruby M van Stein, Simone N Koole

|Jul 09, 2025

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Zakile A Mfumbilwa, Janneke A Wilschut, Harry J M Groen

|Jun 02, 2025

Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective.

Julie M Vancoppenolle, Silvie H M Janssen, Nora Franzen

|Dec 16, 2024

An early economic evaluation of active surveillance for low-risk ductal carcinoma <i>in situ</i>.

Danalyn Byng, Michael Schaapveld, Esther H Lips

|Sep 11, 2024

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers.

Joost G E Verbeek, Leyla Azarang, Luis E Pilli

Pageof 4

Frequent Collaborators

5 joint publications

Wim van Harten

4 joint publications

Martijn Simons

4 joint publications

Bram Ramaekers

4 joint publications

Manuela Joore

4 joint publications

Zakile A Mfumbilwa

4 joint publications

Veerle M H Coupé

3 joint publications

Janneke A Wilschut

3 joint publications

Danalyn Byng

2 joint publications

Joanne M Mankor

2 joint publications

Joachim G J V Aerts

Frequent Collaborators

5 joint publications

Wim van Harten

4 joint publications

Martijn Simons

4 joint publications

Bram Ramaekers

4 joint publications

Manuela Joore

Top Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases <em>via</em> Explainable AI and Agentic Systems

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases <em>via</em> Explainable AI and Agentic Systems

Published on : Jun 13, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on : Jul 18, 2016

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases <em>via</em> Explainable AI and Agentic Systems

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases <em>via</em> Explainable AI and Agentic Systems

Published on : Jun 13, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on : Jul 18, 2016

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos